Advertisements


Esperion Therapeutics Inc (ESPR): Get It While It’s Cheap

At the end of last week, Amgen, Inc. (NASDAQ:AMGN) announced some data from its large-scale trial of its cardiovascular risk asset Repatha.....»»

Category: topSource: insidermonkeyMar 20th, 2017

Esperion Therapeutics (ESPR) Presents At ACC 66th Annual Scientific Session (Genetic Validation of ACL) - Slideshow

Esperion Therapeutics (ESPR) Presents At ACC 66th Annual Scientific Session (Genetic Validation of ACL) - Slideshow.....»»

Category: topSource: seekingalphaMar 20th, 2017

Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 8.6%

Zacks.....»»

Category: topSource: redinewsMar 9th, 2017

Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 8.6%

Esperion Therapeutics, Inc. (ESPR) moved big last session, as its shares rose above 8% on the day. .....»»

Category: topSource: zacksMar 9th, 2017

Esperion Provides Bempedoic Acid Development Program Update; Reports Fourth Quarter and Full Year 2016 Financial Results

ANN ARBOR, Mich., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the lipid management company focused on d.....»»

Category: earningsSource: benzingaFeb 22nd, 2017

Esperion Surge May Be Fueled By Repatha Short Squeeze

Esperion Therapeutics Inc (NASDAQ: ESPR) has maintained its upward momentum on Tuesday, surging higher by another 13.2 percent. read more.....»»

Category: blogSource: benzingaFeb 7th, 2017

What’s Next For Esperion Therapeutics Inc (ESPR)?

Esperion Therapeutics Inc (NASDAQ:ESPR) picked up strength at the end of last week, on the back of some news that – at first glance – seems unr.....»»

Category: topSource: insidermonkeyFeb 6th, 2017

Esperion Therapeutics (ESPR) Presents At 35th Annual J.P. Morgan Healthcare Conference

Esperion Therapeutics (ESPR) Presents At 35th Annual J.P. Morgan Healthcare Conference.....»»

Category: topSource: seekingalphaJan 11th, 2017

Esperion Therapeutics Inc (ESPR): Smart Money Doubles Down

You probably know from experience that there is not as much information on small-cap companies as there is on large companies. Of course, this makes it really hard and difficult for individual investors to make proper and accurate analysis of certain smal.....»»

Category: topSource: insidermonkeyDec 9th, 2016

Top-Line Data For Esperion"s Bempedoic Acid Creates Question About Whether There Is A Place In The Market For It

Following the release of top-line results from the eight-week mid-state study of Esperion Therapeutics Inc (NASDAQ: ESPR)'s bempedoic acid, Chardan said safety concerns on adding it to high-dose statins triggers a question whether there is any market for .....»»

Category: blogSource: benzingaOct 13th, 2016

Esperion Therapeutics (ESPR) in Focus: Stock Jumps 18.1%

Zacks.....»»

Category: topSource: redinewsSep 21st, 2016

Esperion Therapeutics (ESPR) in Focus: Stock Jumps 18.1%

Esperion Therapeutics, Inc. (ESPR) moved big last session, as its shares jumped a little over 18% on the day. Esperion Therapeutics, Inc. ESPR was a big mover last session, as its shares rose a little over 18% on the day. The move came on solid.....»»

Category: topSource: zacksSep 21st, 2016

Massive Biotech Trade Highlights Insider Selling: Esperion Therapeutics, Adobe, Hilton, Fresh Del Monte and More

While the insider selling slowed somewhat, top executives are still taking the chance to sell shares before the windows for trading start to close for earnings......»»

Category: blogSource: 247wallstMar 25th, 2017

Here"s What Pushed Esperion Therapeutics Inc Stock Higher Today

The Esperion rollercoaster is climbing again after an encouraging signal from the FDA......»»

Category: topSource: foxnewsMar 20th, 2017

Nektar, AMD, Esperion, and More: Here’s Why These Five Stocks Are Surging

Although the broader markets are relatively calm, five stocks, Nektar Therapeutics (NASDAQ:NKTR), Advanced Micro Devices, Inc. (NASDAQ:AMD), .....»»

Category: topSource: insidermonkeyMar 20th, 2017

Esperion Therapeutics Rockets 70% Higher After Big Selloff

Esperion Th.....»»

Category: blogSource: benzingaMar 20th, 2017

Esperion Therapeutics stock surges 52% after it says the FDA gave its drug program positive feedback

Esperion Therapeutics Inc. shares surged 52.0% in mor.....»»

Category: topSource: marketwatchMar 20th, 2017

Monday’s Top Biopharma Movers

Esperion Therapeutics and a few other biopharma stocks made massive runs on Monday morning......»»

Category: blogSource: 247wallstMar 20th, 2017

Here"s Why Amgen, The Medicines Company, and Esperion Therapeutics Are All Tanking Today

Shares of several biotech companies dropped after Amgen released important data from a long-term clinical trial that came up short of Wall Street's expectations......»»

Category: topSource: foxnewsMar 17th, 2017

Here's Why Amgen, The Medicines Company, and Esperion Therapeutics Are All Tanking Today - Motley Fool

Motley FoolHere's Why Amgen, The Medicines Company, and Esperion Therapeutics Are All Tanking TodayMotley FoolShares of several biotech companies dr.....»»

Category: topSource: googlenewsMar 17th, 2017

First Week of April 21st Options Trading For Esperion Therapeutics

Stock Options Channel.....»»

Category: topSource: redinewsFeb 22nd, 2017